Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Triple' returned 3609 results - Page 1 of 181   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Triple-Play Forecasts   Digital TV Research, July 2011, Pages: 153 Triple-Play Forecasts More than a quarter of the world's TV households will subscribe to triple-play services (3P - TV, broadband and telephony) by 2016, according to Digital TV Research. The Triple Triple Analysis: Leukemia, Lymphoma and Melanoma   Bioseeker, May 2011, Pages: 2878 Triple Analysis: Leukemia, Lymphoma and Melanoma This triple analysis focuses on cancer drug development strategies in Leukemia, Lymphoma and Melanoma. Each of these three individual parts Triple Analysis: Leukemia, Lymphoma and Angiogenesis   Bioseeker, Jan 2012, Pages: 3805 Triple Analysis: Leukemia, Lymphoma and Angiogenesis This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the mechanism/target/effect Triple Analysis: Leukemia, Lymphoma and Peptides   Bioseeker, Nov 2011, Pages: 3007 Triple Analysis: Leukemia, Lymphoma and Peptides This triple analysis focuses on cancer drug development strategies in both Leukemia and Lymphoma and by the compound strategy of Peptides. Each Triple Analysis: Leukemia, Melanoma and Apoptosis   Bioseeker, Dec 2011, Pages: 3541 Triple Analysis: Leukemia, Melanoma and Apoptosis This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the mechanism/target/effect of Apoptosis Triple Analysis: Leukemia, Melanoma and Peptides   Bioseeker, Nov 2011, Pages: 2830 Triple Analysis: Leukemia, Melanoma and Peptides This triple analysis focuses on cancer drug development strategies in both Leukemia and Melanoma and by the compound strategy of Peptides. Each Triple Analysis: Leukemia, Angiogenesis and Peptides   Bioseeker, Jan 2012, Pages: 3757 Triple Analysis: Leukemia, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Leukemia), one mechanism/target/effect area Triple Analysis: Leukemia, Antibodies and Peptides   Bioseeker, Nov 2011, Pages: 3997 Triple Analysis: Leukemia, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Leukemia and by the two compound strategies of Antibodies and Peptides. Each Triple Analysis: Lymphoma, Melanoma and Angiogenesis   Bioseeker, Jan 2012, Pages: 3435 Triple Analysis: Lymphoma, Melanoma and Angiogenesis This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the mechanism/target/effect Triple Analysis: Lymphoma, Melanoma and Antibodies   Bioseeker, Sep 2011, Pages: 3675 Triple Analysis: Lymphoma, Melanoma and Antibodies This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Antibodies. Each Triple Analysis: Lymphoma, Melanoma and Peptides   Bioseeker, Nov 2011, Pages: 2637 Triple Analysis: Lymphoma, Melanoma and Peptides This triple analysis focuses on cancer drug development strategies in both Lymphoma and Melanoma and by the compound strategy of Peptides. Each Triple Analysis: Lymphoma, Angiogenesis and Antibodies   Bioseeker, Jan 2012, Pages: 4602 Triple Analysis: Lymphoma, Angiogenesis and Antibodies This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect Triple Analysis: Lymphoma, Angiogenesis and Peptides   Bioseeker, Jan 2012, Pages: 3564 Triple Analysis: Lymphoma, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Lymphoma), one mechanism/target/effect area Triple Analysis: Lymphoma, Antibodies and Peptides   Bioseeker, Nov 2011, Pages: 3804 Triple Analysis: Lymphoma, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Lymphoma and by the two compound strategies of Antibodies and Peptides. Each Triple Analysis: Melanoma, Angiogenesis and Antibodies   Bioseeker, Jan 2012, Pages: 4425 Triple Analysis: Melanoma, Angiogenesis and Antibodies This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect Triple Analysis: Melanoma, Angiogenesis and Peptides   Bioseeker, Jan 2012, Pages: 3387 Triple Analysis: Melanoma, Angiogenesis and Peptides This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area Triple Analysis: Melanoma, Antibodies and Peptides   Bioseeker, Nov 2011, Pages: 3627 Triple Analysis: Melanoma, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies in Melanoma and by the two compound strategies of Antibodies and Peptides. Each Triple Analysis: Angiogenesis, Antibodies and Peptides   Bioseeker, Jan 2012, Pages: 4554 Triple Analysis: Angiogenesis, Antibodies and Peptides This triple analysis focuses on cancer drug development strategies by the mechanism/target/effect of Angiogenesis and by the two compound Global Triple Play and Next-generation Services Test and Monitoring   Frost & Sullivan, Dec 2011, Pages: 90 Global Triple Play and Next-generation Services Test and Monitoring World Integrated Triple Play Test and Monitoring Equipment Market to Grow from $187.7 million in 2010 to $487.4 million by 2015 Hygiene and the Triple Bottom Line   Euromonitor International, Jan 2012, Pages: 41 Hygiene and the Triple Bottom Line Although green products constitute only a small share of even the most developed hygiene markets, environmental issues now permeate from raw material extraction Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network